(Q47951600)

7 February 2018

title

Interleukin-6 N-terminal peptides modulate the expression of junB protooncogene and the production of fibrinogen in HepG2 cells (English)

1 reference

7 February 2018

author

Peter Igaz

3

1 reference

7 February 2018

András Falus

6

1 reference

7 February 2018

author name string

Szilvia Bosze

1

1 reference

7 February 2018

Ferenc Hudecz

2

1 reference

7 February 2018

Zsuzsanna Ortutay

4

1 reference

7 February 2018

Gabriella Csík

5

1 reference

7 February 2018

Sára Tóth

7

1 reference

7 February 2018

publication date

1 March 2003

1 reference

7 February 2018

published in

Biological Chemistry

1 reference

7 February 2018

volume

384

1 reference

7 February 2018

issue

3

1 reference

7 February 2018

page(s)

409-421

1 reference

7 February 2018

Internal deletions of amino acids 29-42 of human interleukin-6 (IL-6) differentially affect bioactivity and folding.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Haemopoietic receptors and helical cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Identification of residues in the putative 5th helical region of human interleukin-6, important for activation of the IL-6 signal transducer, gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Structure, stability and biological properties of a N-terminally truncated form of recombinant human interleukin-6 containing a single disulfide bond

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Signal transduction. Just another signalling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Internal deletions in human interleukin-6: structure-function analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

IL-6 type cytokine receptor complexes: hexamer, tetramer or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

C-terminal peptides of interleukin-6 modulate the expression of junB protooncogene and the production of fibrinogen by HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Jaks and Stats in signaling by the cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

An altered repertoire of fos/jun (AP-1) at the onset of replicative senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Cytokine signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

An alternative regulatory pathway of the acute phase response: the role of fibroblast-derived interferon-beta 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Structure-function analysis of human interleukin-6. Evidence for the involvement of the carboxy-terminus in function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Site-specific mutagenesis of human interleukin-6 and its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Glycosylation of interleukin-6 purified from normal human blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Roles of disulfide bonds in recombinant human interleukin 6 conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Potential use of recombinant human interleukin-6 in clinical oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Role of the C-terminus in the activity, conformation, and stability of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Solution structure of recombinant human interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

COVALENT STRUCTURE OF FIBRINOGEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Preparation and application of the 5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)-valeric acid (PAL) handle for the solid-phase synthesis of C-terminal peptide amides under mild conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Analysis of human/mouse interleukin-6 hybrid proteins: both amino and carboxy termini of human interleukin-6 are required forin vitro receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

Synthesis and characterization of 4-ethoxymethylene-2-[1]-naphthyl-5(4H)-oxazolone and its fluorescent amino acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2003.047

21 January 2018

Identifiers

DOI

10.1515/BC.2003.047

1 reference

7 February 2018

PubMed ID

12715892

1 reference

7 February 2018